Dr. Annalisa Botta
Annalisa Botta is a Researcher Assistant at the Medical Genetics Section of the Department of Biomedicine and Prevention. She started her career in 1994 as a research fellow at the University of Rome “Tor Vergata” Tor Vergata studying the genetics of Mendelian disorders (Cystic fibrosis, Thomsen disease and DiGeorge syndrome). She continued her work on DiGeorge Syndrome becoming Research Assistant at Baylor College of Medicine in Houston, Texas. She collaborated with Prof. Allan Bradley to develop the first mouse model of DiGeorge syndrome using the Cre-LoxP technology. In 2002, she obtained the medical specialty in Medical Genetics at “La Sapienza” University of Rome and in 2004 she became Researcher at the Medical Genetics Section of Tor Vergata University. At present, she coordinates a neuromuscular unit which undertakes a broad spectrum of research, from the definition of the molecular basis of neuromuscular diseases to translational projects involving gene therapy strategies. In the last years, Dr. Botta has also focused her activity in the study of epigenetics mechanisms underlying Mendelian and complex diseases.
Dr. Botta has over 70 original scientific publications on peer reviewed journal, 1400 citations and her H-index is 19 (updated to 2018, Source: Scopus).
She is also teaching Professor of Medical Genetics at the Italian and International Medical School of Tor Vergata University.